Login to Your Account


Japan's MHLW looks to build entrepreneurial biomedical ecosystem

By Kohei Kanayasu
Staff Writer

Wednesday, March 15, 2017

TOKYO – Despite being home to world-class biomedical research and large innovative drug and device companies, a lack of an entrepreneurial ecosystem has emerged as a significant challenge for the biotech and med-tech industries. That is a challenge that regulators are now trying to address and overcome.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription